News

Stakeholders seek flexibility, greater harmonization in FDA human subject protection rules

Published on January 5, 2023

News

CDER approved 37 novel drugs in 2022, its lowest number since 2016

Published on January 5, 2023

News

Biopharmas left Black and Latinx patients behind in oncology clinical trials, nonprofit says

Published on January 5, 2023

News

Standardized Eligibility Criteria Aim to Simplify, Expand Access to Cancer Clinical Trials

Published on October 7, 2022

Advocacy Event Recap

Friends of Cancer Research Webinar for Patient Advocates: ctDNA as a Biomarker in Cancer Treatment

Published on August 12, 2022